Double-Blind, Randomized, Comparative Study of Meditoxin® Versus Botox® in the Treatment of Essential Blepharospasm
Jin Sook Yoon, Jae Chan Kim, Sang Yeul Lee
Korean J Ophthalmol. 2009;23(3):137-141.   Published online 2009 Sep 8     DOI:
Citations to this article as recorded by Crossref logo
Effectiveness of different doses of botulinum neurotoxin in lateral epicondylalgia: A network meta-analysis
Yu-Chi Su, Yao-Hong Guo, Pei-Chun Hsieh, Yu-Ching Lin
Annals of Physical and Rehabilitation Medicine.2023; 66(3): 101711.     CrossRef
Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yun Chen, Chia-Hsuan Tsai, Tae Hui Bae, Ching-Ya Huang, Chiehfeng Chen, Yi-No Kang, Wen-Kuan Chiu
Aesthetic Plastic Surgery.2023; 47(2): 775.     CrossRef
Botulinum toxin type A for controlling bruxism assessed with computerized occlusal analysis: A pilot study
Nícea B. Pardo, Robert B. Kerstein, Mario C. Júnior, Leila S. Ferreira, Márcio Abrahão
CRANIO®.2022; 40(3): 207.     CrossRef
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice
Jörg Wissel, Songjin Ri
Expert Review of Neurotherapeutics.2022; 22(1): 27.     CrossRef
A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis
Dong Geon Lee, Jung Eun Kim, Woo Shun Lee, Moon-Bum Kim, Chang-hun Huh, Yang Won Lee, Gwang Seong Choi, Jee-Bum Lee, Dong Soo Yu, Min Kyung Shin, Mi Ryung Roh, Hyo Hyun Ahn, Won-serk Kim, Jong Hee Lee, Kui Young Park, Jin Park, Weon Ju Lee, Mi Youn Park,
Aesthetic Plastic Surgery.2022; 46(3): 1400.     CrossRef
Efficacy and safety of neuronox® for lateral canthal lines: a phase I/III, multicenter, randomized, double-blind, active-controlled study
Youngkyoung Lim, Jong Hee Lee, Woo Shun Lee, Weon Ju Lee, Hei Sung Kim, Min Kyung Shin, Sik Haw, Chang-Hun Huh
Journal of Dermatological Treatment.2021; 32(5): 561.     CrossRef
Neue Botulinumtoxine in der ästhetischen Dermatologie
A. Patil, M. Kassir, U. Wollina, M. Goldust
Der Hautarzt.2021; 72(5): 393.     CrossRef
Practical Application of Novel Test Methods to Evaluate the Potency of Botulinum Toxin: A Comparison Analysis among Widely Used Products in Korea
Ji-Yeon Hong, Jong-Hee Kim, Jung-Eun Jin, Sun-Hye Shin, Kui-Young Park
Toxins.2021; 13(12): 833.     CrossRef
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
Lauren L. Spiegel, Jill L. Ostrem, Ian O. Bledsoe
Toxins.2020; 12(5): 332.     CrossRef
Hemifacial spasm
Z.A. Zalyalova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2020; 120(8): 140.     CrossRef
Six-Month Comparative Analysis Monitoring the Progression of the Largest Diameter of the Sweating Inhibition Halo of Different Botulinum Toxins Type-A
Adilson da Costa, Elisangela Samartin Pegas Pereira, Margareth de Oliveira Pereira, Felipe Borba Calixto dos Santos, Raquel Fávaro, Lissa Sabino de Matos, Thaísa Saddi Tannous, Carla Oliveira Parra Duarte, Caroline Silva Pereira
Aesthetic Surgery Journal.2019; 39(9): 993.     CrossRef
Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study
Sayali Sane, Mohammad Javed Ali, Milind N Naik
Korean Journal of Ophthalmology.2019; 33(5): 430.     CrossRef
Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia
Yong-Soo Byun, Sung-Eun Kim, Ji-Sun Paik, Suk-Woo Yang, Radouil Tzekov
PLOS ONE.2019; 14(6): e0217924.     CrossRef
Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
Seunghyun Lee, Sangrye Park, Helen Lew
Korean Journal of Ophthalmology.2018; 32(1): 1.     CrossRef
Chemodenervation for the Treatment of Facial Dystonia
Jurij R. Bilyk, Michael T. Yen, Elizabeth A. Bradley, Edward J. Wladis, Louise A. Mawn
Ophthalmology.2018; 125(9): 1459.     CrossRef
Current Uses of Botulinum Neurotoxins in Plastic Surgery
Marie E. Noland, Donald H. Lalonde, G. Jackie Yee, Rod J. Rohrich
Plastic & Reconstructive Surgery.2016; 138(3): 519e.     CrossRef
Comparative Study of Hugel-tox® versus Botox® for the Treatment of Essential Blepharospasm
Jee Hye Lee, Su Kyung Jung, Ji Sun Baik, Suk Woo Yang
Journal of the Korean Ophthalmological Society.2015; 56(6): 811.     CrossRef
Outcome measures used for the assessment of blepharospasm patients treated with botulinum toxin
Marina C Parker, Paula Waddingham
International Journal of Ophthalmic Practice.2014; 5(1): 30.     CrossRef
Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study
Chong H. Won, Hyung M. Lee, Woo S. Lee, Hoon Kang, Beom J. Kim, Won S. Kim, Ju H. Lee, Dong H. Lee, Chang H. Huh
Dermatologic Surgery.2013; 39(1): 171.     CrossRef
A New Botulinum Toxin Potentially Bioequivalent to OnabotulinumtoxinA: Are There Any Differences at All?
Gi-Hyeok Yang, Hyun Ho Jung
Dermatologic Surgery.2013; 39(1): 165.     CrossRef
Alastair Carruthers, Jean Carruthers
Dermatologic Surgery.2013; 39(1): 149.     CrossRef
A Pharmacodynamic Comparison Study of Different Botulinum Toxin Type A Preparations
Sung-Beom Kim, Bhupal Ban, Keun-Suk Jung, Gi-Hyeok Yang
Dermatologic Surgery.2013; 39(1): 150.     CrossRef
Botulinum toxins in the treatment of primary focal dystonias
Daniel Truong
Journal of the Neurological Sciences.2012; 316(1-2): 9.     CrossRef
Botulinum Toxin for the Treatment of Movement Disorders
Mary Ann Thenganatt, Stanley Fahn
Current Neurology and Neuroscience Reports.2012; 12(4): 399.     CrossRef
Uses of Botulinum Toxin a in Ophthalmology
Livia Teo, Elaine Chee
Proceedings of Singapore Healthcare.2012; 21(1): 30.     CrossRef
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
Bettina Wabbels, Wolfgang H. Jost, Peter Roggenkämper
Journal of Neural Transmission.2011; 118(6): 925.     CrossRef